Literature DB >> 2414308

A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens.

K C McCullough, J R Crowther, R N Butcher.   

Abstract

An enzyme-linked immunosorbent assay was developed which would detect antigen/antibody reactions in liquid-phase; that is under test conditions which should not alter the structure or reactivity of either antigen or antibody. This liquid-phase ELISA was at least as efficient, both qualitatively and quantitatively, as the double sandwich or antigen-trapping ELISA (Crowther and Abu Elzein, 1979), but six to eight times more sensitive than the indirect ELISA. The liquid-phase test can be used to assay both antisera and hybridoma cultures, and will show the greatest discrimination of antibody specificities. Since the liquid-phase ELISA will detect antibody/antigen reactions which are of direct relevance to the protective immune response in vivo (opsonisation; neutralisation of pathogen infectivity), it is recommended that this assay should be used to characterise the antibody reactivity of antisera and hybridoma culture supernatants.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414308     DOI: 10.1016/0166-0934(85)90026-6

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

Review 1.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

2.  Immune responses of sheep to quadrivalent double emulsion foot-and-mouth disease vaccines: rate of development of immunity and variations among other ruminants.

Authors:  Prasanna K Patil; Jagadeesh Bayry; Chitimalla Ramakrishna; Basavesh Hugar; Laxmi D Misra; Krishnamsetty Prabhudas; C Natarajan
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies.

Authors:  K C McCullough; J R Crowther; R N Butcher; W C Carpenter; E Brocchi; L Capucci; F De Simone
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

4.  Opsonization-enhanced phagocytosis of foot-and-mouth disease virus.

Authors:  K C McCullough; D Parkinson; J R Crowther
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

5.  Epitopes functional in neutralization of varicella-zoster virus.

Authors:  B Forghani; K W Dupuis; N J Schmidt
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

6.  Monoclonal and polyclonal antibodies specific for foot and mouth disease virus type A and type O VP1.

Authors:  Jin Gu Cho; Yeong Joon Jo; Jong-Hyuk Sung; Jang-Kwan Hong; Ji-Hyeon Hwang; Jong-Hyeon Park; Kwang-Nyeong Lee; Sang Gyu Park
Journal:  Hybridoma (Larchmt)       Date:  2012-10

Review 7.  Protective immune response against foot-and-mouth disease.

Authors:  K C McCullough; F De Simone; E Brocchi; L Capucci; J R Crowther; U Kihm
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Development of a competitive enzyme-linked immunosorbent assay for detection of antibodies against the 3B protein of foot-and-mouth disease virus.

Authors:  Ming Yang; Satya Parida; Tim Salo; Kate Hole; Lauro Velazquez-Salinas; Alfonso Clavijo
Journal:  Clin Vaccine Immunol       Date:  2015-02-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.